Nutritional Supplementation in Adults With Chronic Respiratory Disease
NCT ID: NCT02102009
Last Updated: 2019-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2014-04-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.
NCT02251496
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD
NCT04432194
Emphysema: Physiologic Effects of Nutritional Support
NCT00000573
Effect of Oral Feeding on Patients With Chronic Obstructive Pulmonary Disease
NCT06505876
The Effect of a Respiratory Muscle Warm-up Prior to Exercise in Patients With Chronic Obstructive Pulmonary Disease
NCT02532075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitafos
Complete enteral formula
Complete enteral formula
Product: Complete nutritional formula in powder enriched with key nutrients to be administered orally (200 ml of water per 57 g product).
Time of intervention: 3 months.
Dietary Advise
Dietary advise according to the hospital routine clinical practice.
Dietary Advise
Patients will receive the usual dietary advise in these patients according hospital clinical practice .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complete enteral formula
Product: Complete nutritional formula in powder enriched with key nutrients to be administered orally (200 ml of water per 57 g product).
Time of intervention: 3 months.
Dietary Advise
Patients will receive the usual dietary advise in these patients according hospital clinical practice .
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient from Clínica San Gabriel or Clínica San Pablo Surco, inpatient or outpatient.
* Patients with chronic pulmonary disease (including bronchiectasis, tuberculosis specific sequel, fibrothorax, diffuse interstitial lung disease, COPD).
* Patients presenting one or more of the following situations of malnutrition or nutritional risk: BMI \<21 kg/m2 (or\<23 kg/m2 in patients ≥ 65); unintentional weight loss \>10% in the past 6 months; unintentional weight loss \>5% in last moth; FFMI \<15 kg/m2 (women) or \<16 kg/m2 (men).
* Patients who signed informed consent.
Exclusion Criteria
* Patients requiring other nutritional supplements or parenteral nutrition.
* Patients diagnosed with active pulmonary tuberculosis.
* Patients with acute respiratory failure.
* Patients with immunosuppression (including HIV, diabetes or neoplasms).
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peruvian Clinical Research
OTHER
Laboratorios Ordesa
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Antonio Camere Torrealva, Doctor
Role: PRINCIPAL_INVESTIGATOR
Clínica San Gabriel - Perú
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clínica San Gabriel
San Miguel, Lima region, Peru
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OFOS-01-012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.